BHP Billiton Limited vs Heron Therapeutics Inc — how do they compare? BHP Billiton Limited trades at $90.96 (market cap $229.15B), while Heron Therapeutics Inc trades at $0.31 (market cap $61.47M). The key difference: BHP Billiton Limited is far larger — about 3727.8× Heron Therapeutics Inc's market cap, and BHP Billiton Limited pays a 2.95% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| BHP | HRTX | |
|---|---|---|
Market Cap | $229.15B | $61.47M |
Sector | Basic Materials | Health |
52-Week High | $93.15 | $1.49 |
52-Week Low | $52.14 | $0.32 |
Enterprise Value | $243.35B | $168.21M |
Dividend Yield | 2.95% | — |
Signals from Pluang's Aura AI — not financial advice
BHP trades at $90.61, up 0.22% with a bullish technical signal supported by moving averages. The company reported mixed Q4 2025 earnings, missing EPS estimates but maintaining strong profitability with 18.97% net margins. Recent operational challenges include strikes at Port Hedland iron ore operations, while copper production declines in Chile. Valuation metrics show a P/E of 22.36 and P/B of 4.54, reflecting premium pricing relative to historical levels.
The outlook remains cautiously optimistic with analyst consensus leaning hold (64.52%) amid labor disputes and production volatility. Key opportunities include exposure to AI-driven copper demand growth, while risks center on strike impacts and fluctuating commodity prices. The stock's current technical strength faces fundamental headwinds from operational disruptions.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
BHP Group Limited operates as a mining company. The Company engages in the exploration, development, production, and processing of iron ore, metallurgical coal, and copper. BHP Group serves customers worldwide.
Read more on BHP →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →